Beyond Air (XAIR) to Release Earnings on Friday

Beyond Air (NASDAQ:XAIR) is expected to be releasing its Q3 2026 results before the market opens on Friday, February 13th. Analysts expect Beyond Air to post earnings of ($0.54) per share and revenue of $2.1460 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q3 2026 earning overview page for the latest details on the call scheduled for Friday, February 13, 2026 at 8:00 AM ET.

Beyond Air (NASDAQ:XAIR) last announced its quarterly earnings data on Monday, November 10th. The company reported ($1.25) earnings per share for the quarter, missing the consensus estimate of ($1.10) by ($0.15). Beyond Air had a negative net margin of 632.51% and a negative return on equity of 261.08%. The company had revenue of $1.82 million for the quarter, compared to analyst estimates of $2.54 million. On average, analysts expect Beyond Air to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Beyond Air Stock Performance

Shares of Beyond Air stock opened at $1.08 on Wednesday. Beyond Air has a one year low of $0.67 and a one year high of $10.40. The firm has a market capitalization of $8.65 million, a price-to-earnings ratio of -0.14 and a beta of 0.39. The business has a 50-day simple moving average of $1.15 and a 200 day simple moving average of $1.84. The company has a debt-to-equity ratio of 0.77, a current ratio of 4.24 and a quick ratio of 3.73.

Hedge Funds Weigh In On Beyond Air

Several institutional investors have recently modified their holdings of XAIR. Virtu Financial LLC bought a new stake in Beyond Air during the third quarter worth $48,000. Geode Capital Management LLC increased its position in shares of Beyond Air by 57.5% during the 4th quarter. Geode Capital Management LLC now owns 67,678 shares of the company’s stock valued at $49,000 after purchasing an additional 24,695 shares during the last quarter. Osaic Holdings Inc. raised its stake in shares of Beyond Air by 26.4% during the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock worth $29,000 after purchasing an additional 34,000 shares during the period. Finally, Alyeska Investment Group L.P. purchased a new position in shares of Beyond Air in the 3rd quarter worth about $1,753,000. 31.50% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on XAIR shares. Rodman & Renshaw began coverage on Beyond Air in a report on Tuesday, January 20th. They set a “buy” rating for the company. Weiss Ratings restated a “sell (e)” rating on shares of Beyond Air in a research note on Monday, December 22nd. Finally, D. Boral Capital reaffirmed a “buy” rating and issued a $11.00 price objective on shares of Beyond Air in a research note on Wednesday, January 21st. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $11.00.

About Beyond Air

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.